A new study finds that harms of overdiagnosing prostate cancer is lessened when MRI is used as well as PSA tests.

MRI around the time of diagnostic biopsy may identify patients at increased risk for early reclassification during prostate cancer active surveillance.

Omitting biopsy in patients with negative magnetic resonance imaging (MRI) results is associated with a significantly reduced ...

Omitting biopsy in patients with negative magnetic resonance imaging (MRI) results is associated with a significantly reduced ...

Detection of clinically insignificant ISUP grade group 1 prostate cancer decreases by 57% under a prostate cancer screening strategy of MRI-targeted biopsy only rather than systematic biopsy in men ...

Researchers at Case Western Reserve University and Vanderbilt University are pioneering a new approach to prostate cancer ...

Data on the efficacy and safety of screening for prostate cancer with magnetic resonance imaging (MRI) are needed from studies of follow-up screening. In a population-based trial that started in ...

"Omitting prostate biopsy in men with negative MRI results, and thereby delaying a potential cancer diagnosis, was associated with a substantial reduction in the detection of clinically ...

Know about Prostate cancer as it has significant impact on men's health. Here are the details about this disease.

HOUSTON — September is Prostate Cancer Awareness Month. One in eight men will be diagnosed during their lifetime, and it's ...